• Explore /
  • Poster
  • / Efficacy of first-line combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS).

Efficacy of first-line combination therapy in metastatic renal cell carcinoma (mRCC) patients (pts) with poor performance status (PS).

Abstract Poster

Authors

null

Lucia Carril

Institut Gustave Roussy, Villejuif, France

Lucia Carril , Emeline Colomba , Carmen Romero-Ferreiro , Luigi Cerbone , Raffaele Ratta , Philippe Barthélémy , Clarisse Vindry , Francois Cherifi , Elouen Boughalem , Claude Linassier , Giuseppe Fornarini , Marine Gross-Goupil , Carolina Saldana , Maria Cruz Martin Soberón , Guillermo de Velasco , Cristina Pernaut , Carolina Alves Costa Silva , Ronan Flippot , Bernard Escudier , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 320)

DOI

10.1200/JCO.2022.40.6_suppl.320

Abstract #

320

Poster Bd #

E9

Abstract Disclosures

Similar Posters

First Author: Martin Boegemann

First Author: Ana-Alicia Beltran-Bless

First Author: Philipp Ivanyi

First Author: Pratik Rane